Details for 2016835723
Up to date per 04.04.2026
Actions
Details for 2016835723
Granted/Registered
European Patent
13.06.2018 A
28.04.2021 B1
07.08.2015
US
201562202772 P
07.08.2015
US
201562202775 P
07.08.2015
US
201562202779 P
10.12.2015
US
201562265887 P
08.01.2016
US
201662276801 P
08.01.2016
US
201662276796 P
06.06.2016
US
201662346414 P
C07K 14/705 20060101AFI20200925BHEP
Owner
ALX Oncology Inc.866 Malcolm Road, Suite 100 Burlingame, CA 94010US
Representative
Representative
Patentanwaltskanzlei Matschnig & Forsthuber OGBiberstraße 221010 WienAT
Inventor
PONS, Jaume951 Gateway Boulevard Suite 201 South San Francisco, California 94080US
DEMING, Laura951 Gateway Boulevard Suite 201 South San Francisco, California 94080US
GOODMAN, Corey951 Gateway Boulevard Suite 201 South San Francisco, California 94080US
SIM, Bang Janet951 Gateway Boulevard Suite 201 South San Francisco, California 94080US
KAUDER, Steven Elliot951 Gateway Boulevard Suite 201 South San Francisco, California 94080US
WAN, Hong951 Gateway Boulevard Suite 201 South San Francisco, California 94080US
KUO, Tracy Chia-Chien951 Gateway Boulevard Suite 201 South San Francisco, California 94080US
Information about Fees